Product NamePioglitazone Hydrochloride, Capsule/Oral Solution
Active IngredientActos (Estradiol) / Dihydro actoside
IndicationPioglitazone hydrochloride is used to treat high blood pressure, heart failure, or angina. It works by relaxing the walls of the blood vessels and increasing blood flow. This medicine also works in lowering high blood pressure and controlling heart rhythm.
DosageOral pioglitazone hydrochloride is usually taken once daily. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take the medicine exactly as directed. Do not take more or less medicine or take it more often than prescribed by your doctor.
If you are also taking
Lipitorthen shake the bottle well before each use. Carefully measure the dose using the dosing device on the prescription label. Use the dosing device regularly to ensure the correct dose.
CautionsBefore taking pioglitazone hydrochloride, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. Ask your pharmacist for a list of all the medicines you are taking. Do not use this medicine if you have had an allergic reaction to it or any other medicine.
Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). Your doctor may need to change the dose of your medicine based on the condition you have.
Tell your doctor if your condition does not get better or if it gets worse.
Drowsiness/reduced alertness may occur. Avoid alcohol/by mouth. If you must avoid or drink alcohol while taking this medicine, do so as much as possible. Alcohol can make you drowsy and cause dizziness. Do not drive, use machinery, or do any activity that requires you to be alert. Tell your doctor if you are using or have recently had heart surgery. This medicine may make you feel lightheaded, dizzy, or drowsy. This medicine may decrease the effectiveness of nitroglycerin tablets. Nitrates used in angina, such as isosorbide dinitrate, are also known to cause dilation of the artery.
Children and teenagers may be more sensitive to external heat or cold. Before giving the medicine to a child, tell the doctor or pharmacist your use of this medicine (even if it is not available for your child) or that of your child. This medicine should not be given to a pregnant woman without consulting her doctor. It should not be used in children below 18 years of age.
Use of this medicine during pregnancy may cause harm to the fetus. This medicine should not be used in pregnant women unless it has been clearly needed in the last 12 months of pregnancy and poses a greater risk of harm to the developing baby if it is taken during pregnancy.
This medicine should not be used in children below 18 years of age unless clearly needed in the first 12 months of pregnancy and it is clearly needed in the first 3 months of secondary amenorrhea or beyond. Do not use this medicine in children under 18 years of age unless clearly needed in the first 6 months of secondary amenorrhea or beyond.
Before taking this medicine, tell your doctor or pharmacist if you are allergic to it, or if you have any other allergies.
Do not use this medicine if you are pregnant or may become pregnant. Ask your doctor or pharmacist for a list of ingredients.
Do not use if you are allergic to it or any other medicines. Ask your pharmacist about other medicines that may help you get your condition under control.
The American Diabetes Association is advising the President to avoid the use of the Actos (pioglitazone) and its generic version, pioglitazone, in all diabetes care products.
Actos was originally developed by Eli Lilly, Inc. to treat type 2 diabetes. However, pioglitazone was developed as a treatment for obesity, especially in the elderly. Its popularity grew in the 1990s and has since become the most widely prescribed diabetes medicine.
The American Diabetes Association is advising the President to avoid the use of the Actos and its generic version, pioglitazone, in all diabetes care products.
“This article is to inform you that Actos has been approved for the treatment of type 2 diabetes, which is the leading cause of death in the United States,” says Dr. Diana G. Smith, M. D., associate professor of medicine at the University of North Carolina School of Medicine. “Although Actos was first developed for the treatment of type 2 diabetes, it has been FDA approved for the treatment of obesity and diabetes.”
“Actos has been approved for the treatment of obesity and diabetes for over a decade,” says Dr. Smith, “which is why the FDA has issued new warnings for the use of pioglitazone in the treatment of obesity and diabetes.”
“Pioglitazone has been approved to treat the following diseases: obesity, type 2 diabetes, and diabetic ketoacidosis,” states the article. “For these diseases, the FDA has issued new warnings and new warnings about pioglitazone.”
Actos is not a “first line” medication for all patients with type 2 diabetes. It has been approved for the treatment of obesity and diabetes for more than 50 years.
“Pioglitazone is not recommended for use in patients with obesity or diabetes,” says Dr. G. Richard Geller, M. D., professor of medicine at the University of North Carolina School of Medicine and director of the FDA’s Center for Drug Evaluation and Research. “It is not a first line treatment for all types of diabetes, including obesity and diabetes.”
Actos is not a first line medication for all patients with type 2 diabetes.
“Pioglitazone has been approved to treat obesity and diabetes in the United States,” explains Dr. Geller. “Because of the drug’s side effects, we recommend that patients who are eligible for this treatment receive it at the lowest effective dose.”
The use of pioglitazone is not recommended for patients with diabetes.
The FDA’s Center for Drug Evaluation and Research (CDER) recommends that patients with diabetes with diabetes, a chronic disease or cancer, who have been diagnosed with diabetes, be prescribed a low-dose pioglitazone (0.05 mg/day) for at least two months.
“This drug should be started at the lowest effective dose of pioglitazone for the shortest possible duration,” says Dr.
Actos is not a “third-line” treatment for diabetes. It should be started as soon as possible after the patient’s last dose, and continue indefinitely at a dose not exceeding 25 mg per day.”
The FDA also recommends that patients with diabetes with diabetes, a chronic disease or cancer, who are prescribed a low-dose pioglitazone for at least two months have a minimum effective dose of 400 mg per day for a maximum of seven days.
In some cases, Actos may cause complications such as blood clots, kidney failure and pancreatitis.
“Pioglitazone has been shown to be associated with an increased risk of heart attack and stroke in some patients,” says Dr. “This risk increases with longer treatment.
“If you have been diagnosed with diabetes and you have a history of heart attack or stroke, you should be closely monitored by your doctor to rule out cardiovascular disease.”
“If you are prescribed pioglitazone for your diabetes, the FDA recommends that you start at the lowest effective dose,” states the article. “If you do not see any benefits, you should continue with your current dose.
JUNIOR DEVAS, Jan 12, 2014 /PRNewswire/ --
Novartis Inc. today announced that its subsidiary, Actos, Inc., has launched the first generic version of Actos shoes for sale in stores nationwide.
Actos shoes, which are known by various brand names, have been on sale in over 100 stores nationwide since the launch of Actos shoes on February 11, 2014.
Actos shoes are sold for a variety of reasons including weight loss, aesthetic and aesthetic concerns, and the convenience of online purchasing.
Actos shoes are available in two different ways. The first is a "printer-and-hand" type of shoe sold at a store and then sold by consumers in a store.
The second is a retail-only purchase that is also available at participating stores.
The shoes were approved by the FDA for use in the United States by the end of 2004.
In addition to the brand-name Actos shoes, the company has also launched Actos shoes for sale in stores nationwide, including North America, Canada, and the U. S. Virgin Islands.
The company's U. operations have received regulatory approvals from the U. Food and Drug Administration, the U. Attorney for the District of New Jersey, the National Association of Boards of Pharmacy, the U. Attorney's Office for the Eastern District of New York, the Federal Trade Commission, the Federal Drug Administration and the U. Food and Drug Administration. In addition to its U. operations, the company also has received regulatory approval from the U. Attorney's Office for the Eastern District of New York.
operations, the company also has received approval from the National Association of Boards of Pharmacy and the U.
For more information about Actos shoes, visit the company's website.
SOURCE: Novartis Inc.
Product InformationActos (Pioglitazone) is an antidiabetic drug that helps reduce body weight. It lowers blood sugar and may help prevent diabetes-induced peripheral edema and diabetic ketoacidosis. It is used to treat the symptoms of type 2 diabetes.
Actos is also used to treat symptoms of peripheral arterial hypertension (high blood pressure in the blood vessels of the blood vessels of the brain) and heart failure (poor circulation).
Pioglitazone may be used along with a low-sodium diet to improve symptoms of peripheral edema (fluid retention) and diabetic ketoacidosis (too much acid in the blood).
Actos can be used alone or in combination with other diabetes medications. It is also used to treat symptoms of peripheral arterial hypertension (high blood pressure in the blood vessels of the blood vessels of the brain) and heart failure (poor circulation).
Actos is an antidiabetic drug that helps reduce body weight. It works by blocking the action of the hormone (which regulates blood sugar) that is needed by the body to function. Actos may also help to reduce the risk of developing a cardiovascular event, such as heart attack or stroke, in the future.
Actos should be used along with a low-sodium diet and a low-fats-but-fat diet to improve symptoms of diabetes.
Actos can cause side effects in some people. Common side effects of Actos include dizziness, drowsiness, and weight gain.
Serious side effects of Actos include severe hepatic failure, electrolyte imbalance (diuresis low), bone fracture, and hearing loss ( hearing inversion).
If you have any of these serious side effects, you should seek medical attention immediately.
Some common Actos side effects include blurred vision, double vision, decreased eye movements, blurred vision or double vision, visual disturbance, fatigue, tremors, muscle stiffness, and weakness. Contact your doctor immediately if these side effects worsen or persist for a longer duration.
Do not discontinue Actos or any other diabetes medication without consulting your doctor. Actos can interact with other medications you may be taking, possibly leading to serious side effects or even death. Contact your doctor for more details.
The dosage of Actos is determined by your health condition and response to treatment. For adults, the maximum daily dose is 850 mg.
If you have a heart condition or have had a heart attack, liver or kidney disease, or a stroke, you should avoid Actos. Your doctor will discuss the contraindications and recommendations for each individual case.
Actos Savings Card:$35
Actos Savings Information
The cost of prescription and over-the-counter (OTC) actos is:
Included as part of the price change:
For patients who arenot eligible for a free actos couponbecause they areexcluded in the cost of prescription or OTC actos, the savings card provides a discount for your eligible patients.
Exclusions
You may not receive afree actos couponuntil the offer is accepted and the prescription drug is dispensed.
Discounts for patients with over-the-counter actos
The cost of actos:
Discounts for patients with OTC actos
Discounts for patients with prescription or OTC actos
Stade de France Pharmacy